Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Petros Pharmaceuticals, Inc.PTPI · Entity 8730 | See Remarks | February 19, 2025 | February 21, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Petros Pharmaceuticals, Inc.
Report date February 19, 2025 · Filed February 21, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 150,000 |
Reported balance
After 2025-02-19 transaction · row 1
1 source rowRow 1 · 2025-02-19 · Grant · Acquired 150,000 · Balance 150,000 F1: Represents a grant of restricted shares of common stock, par value $0.0001 per share, of the Issuer granted under the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended. 50% of the shares vest on the first anniversary of the date of grant and the remaining shares vest on the second anniversary on the date of grant, provided that the Reporting Person continues to provide service to the Issuer on the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted shares of common stock, par value $0.0001 per share, of the Issuer granted under the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended. 50% of the shares vest on the first anniversary of the date of grant and the remaining shares vest on the second anniversary on the date of grant, provided that the Reporting Person continues to provide service to the Issuer on the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2025 Filed Feb 21, 2025 22:34 UTC | Petros Pharmaceuticals, Inc. PTPI · Entity 8730 | GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-016202 · tm257316-4_4seq1.xml · nonDerivative · entry 1 Arnold Mitchell · CIK 0001841497 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 F1 · price: Represents a grant of restricted shares of common stock, par value $0.0001 per share, of the Issuer granted under the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended. 50% of the shares vest on the first anniversary of the date of grant and the remaining shares vest on the second anniversary on the date of grant, provided that the Reporting Person continues to provide service to the Issuer on the applicable vesting date. Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 22:06 UTC | Petros Pharmaceuticals, Inc. PTPI · Entity 8730 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001104659-23-129251 · tm2333705-5_4seq1.xml · derivative · entry 1 Arnold Mitchell · CIK 0001841497 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-12-21 F1 · derivative.exercise_date: The stock options vested 100% upon grant. Read SEC document |
| May 11, 2021 Filed Aug 5, 2021 22:02 UTC | Petros Pharmaceuticals, Inc. PTPI · Entity 8730 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0001567619-21-014526 · doc1.xml · derivative · entry 1 Arnold Mitchell · CIK 0001841497 · Prin. Acct. Off/Prin. Fin. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-05-11 F1 · derivative.exercise_date: The shares of common stock underlying the options vested 30% on the date of grant, 30% shall vest upon the first annual anniversary of the date of grant and 40% shall vest upon the second annual anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.